Antiviral drug packaging sales will strengthen through 2036, anchored by rigid plastic at 36.7% of the material segment in 2026. The market was valued at USD 30.70 billion in 2025 and is expected to be worth USD 56.49 billion by 2036, creating an incremental opportunity of USD 24.04 billion.